BridgeMD
New treatment option for Ichthyosis Inherited
Official title Evaluate the Evolution of Body and Scalp Skin Discomfort in Patients With Hereditary Ichthyosis After Wraps (EnvelopIchtyose)
ClinicalTrials.gov ID: NCT05979506
What this study is testing
- What it's testing
- Ichthyosis is a group of rare and chronic genetic diseases beginning at birth, in which the patient's skin is covered with scales of variable appearance and severity. This disease is disabling.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 15 and older
You may be able to join if
- Patient with hereditary ichthyosis regardless of the clinical form
- Patient with a scaling or erythema score \> 6/16
- Patient with a skin discomfort score \> 3/10
- Patient having given written, free and informed consent
- Patient affiliated to a social security scheme
You likely can't join if
- Patient with a skin disease other than ichthyosis
- Patient having modified his treatments for ichthyosis in the month preceding inclusion
- Patient with known intolerance or allergy to one of the topicals used in the study
- Patient unable to complete the study questionnaires
- Patient under a protection regime
The study team makes the final eligibility decision.
Where it's taking place
- Toulouse, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 15 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toulouse, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.